2.38 USD
↘ 0.01 (0.42%)AT CLOSE (11:59 AM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
2.40
↗ 0.02 (0.80%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
2.40
↗ 0.02 (0.80%)
Market: CLOSED
Open?$2.36
High?$2.44
Low?$2.35
Prev. Close?$2.39
Volume?174.8K
Avg. Volume?450.0K
VWAP?$2.40
Rel. Volume?0.39x
Bid / Ask
Bid?$2.36 × 200
Ask?$2.59 × 100
Spread?$0.23
Midpoint?$2.47
Valuation & Ratios
Market Cap?171.9M
Shares Out?72.2M
Float?31.2M
Float %?51.4%
P/E Ratio?N/A
P/B Ratio?2.44
EPS?-$1.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
171.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.07Strong
Quick Ratio?4.07Strong
Cash Ratio?1.80Strong
Debt/Equity?0.44Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.44CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-172.3%WEAK▾
ROA?-98.8%WEAK▾
Cash Flow & Enterprise
FCF?$-115626000
Enterprise Value?$149.1M
Fundamentals ratios updated end of day